Doubly transgenic mice (PSAPP) overexpressing mutant APP and PS1 transgenes were examined using antibodies to A␤ subtypes and glial fibrillary acidic protein (GFAP). Visible A␤ deposition began primarily in the cingulate cortex of PSAPP mice at approximately 10 weeks of age. By 6 months, the mice had extensive amyloid deposition throughout the hippocampus and cortex as well as other regions of the brain. Highly congophilic deposits consisting of N-terminal normal and modified forms of A␤ were identified, reminiscent of those found in human AD brain. Both immunohistochemistry and mass spectrometry showed that A␤42 forms were underrepresented relative to A␤40, and A␤43 was undetectable. Deposits were associated with prominent gliosis which increased with age, but in 14-month-old PSAPP mice, GFAP immunoreactivity in the vicinity of amyloid deposits was substantially reduced compared to APP littermates. These mice have considerable utility in the study of the amyloid phenotype of AD.
INTRODUCTION
Alzheimer's disease (AD) is characterized by the presence in the brain of neurofibrillary tangles and A␤ containing plaques (deposits) that contain multiple A␤ isoforms (Iwatsubo et al., 1996) . These isoforms include A␤ starting at N1 (L-asp) together with the racemized and isomerized forms (D asp and L-iso-asp, respectively), A␤ containing pyroglutamate modified residues at positions N3 and N11, and A␤ starting at N17, which is especially prevalent in diffuse deposits (Gowing et al., 1994) . A␤ C terminal heterogeneity is also a feature of AD, as A␤ isoforms terminating at residues 39, 40, and 42 have been identified in plaques from patients with typical late-onset AD (Iwatsubo et al., 1996) . Patients with PS1 mutations harbored a higher burden, or number, of A␤42 senile plaques compared with patients with sporadic AD (Mann et al., 1996) , most likely due to the effect of mutant PS1 on APP metabolism which leads to specific elevation of the highly fibrillogenic A␤42 peptide (Scheuner et al., 1996; Jarrett et al., 1993) . The identification of AD causing mutations in APP, PS1, and PS2 that affect A␤ levels suggests that A␤ plays a critical role in AD pathogenesis. Transgenic mice that model the deposition process have therefore been generated to study the process of A␤ accumulation and deposition.
Transgenic mice that overexpress mutant and wildtype PS1 cDNAs have been assayed for A␤ levels (Duff et al., 1996) . Mutant PS1 transgenic mice had elevated
